91 related articles for article (PubMed ID: 15496299)
1. Protection by the GABAB receptor antagonist, SCH 50911, of gamma-hydroxybutyric acid-induced mortality in mice.
Carai MA; Colombo G; Gessa GL
Eur J Pharmacol; 2004 Oct; 503(1-3):77-80. PubMed ID: 15496299
[TBL] [Abstract][Full Text] [Related]
2. Resuscitative treatments on 1,4-butanediol mortality in mice.
Carai MA; Colombo G; Quang LS; Maher TJ; Gessa GL
Ann Emerg Med; 2006 Feb; 47(2):184-9. PubMed ID: 16431232
[TBL] [Abstract][Full Text] [Related]
3. Resuscitative effect of a gamma-aminobutyric acid B receptor antagonist on gamma-hydroxybutyric acid mortality in mice.
Carai MA; Colombo G; Gessa GL
Ann Emerg Med; 2005 Jun; 45(6):614-9. PubMed ID: 15940094
[TBL] [Abstract][Full Text] [Related]
4. In vivo effectiveness of CGP7930, a positive allosteric modulator of the GABAB receptor.
Carai MA; Colombo G; Froestl W; Gessa GL
Eur J Pharmacol; 2004 Nov; 504(3):213-6. PubMed ID: 15541424
[TBL] [Abstract][Full Text] [Related]
5. Characterization of the antiabsence effects of SCH 50911, a GABA-B receptor antagonist, in the lethargic mouse, gamma-hydroxybutyrate, and pentylenetetrazole models.
Hosford DA; Wang Y; Liu CC; Snead OC
J Pharmacol Exp Ther; 1995 Sep; 274(3):1399-403. PubMed ID: 7562514
[TBL] [Abstract][Full Text] [Related]
6. Up-regulation of GABA(B) receptors by chronic administration of the GABA(B) receptor antagonist SCH 50,911.
Pibiri F; Carboni G; Carai MA; Gessa GL; Castelli MP
Eur J Pharmacol; 2005 May; 515(1-3):94-8. PubMed ID: 15893746
[TBL] [Abstract][Full Text] [Related]
7. Gamma-aminobutyric acidB (GABAB)-receptor mediation of different in vivo effects of gamma-butyrolactone.
Carai MA; Lobina C; Maccioni P; Cabras C; Colombo G; Gessa GL
J Pharmacol Sci; 2008 Feb; 106(2):199-207. PubMed ID: 18270475
[TBL] [Abstract][Full Text] [Related]
8. Regional Fos-expression induced by γ-hydroxybutyrate (GHB): comparison with γ-butyrolactone (GBL) and effects of co-administration of the GABAB antagonist SCH 50911 and putative GHB antagonist NCS-382.
van Nieuwenhuijzen PS; McGregor IS; Chebib M; Hunt GE
Neuroscience; 2014 Sep; 277():700-15. PubMed ID: 25088910
[TBL] [Abstract][Full Text] [Related]
9. Relation of the [3H] gamma-hydroxybutyric acid (GHB) binding site to the gamma-aminobutyric acidB (GABAB) receptor in rat brain.
Snead OC
Biochem Pharmacol; 1996 Oct; 52(8):1235-43. PubMed ID: 8937431
[TBL] [Abstract][Full Text] [Related]
10. Gamma-hydroxybutyric acid affects the acquisition and reinstatement of cocaine-induced conditioned place preference in mice.
Maldonado C; Rodríguez-Arias M; Castillo A; Aguilar MA; Miñarro J
Behav Pharmacol; 2006 Mar; 17(2):119-31. PubMed ID: 16495720
[TBL] [Abstract][Full Text] [Related]
11. Gamma-hydroxybutyric acid (GHB) and gamma-aminobutyric acidB receptor (GABABR) binding sites are distinctive from one another: molecular evidence.
Wu Y; Ali S; Ahmadian G; Liu CC; Wang YT; Gibson KM; Calver AR; Francis J; Pangalos MN; Carter Snead O
Neuropharmacology; 2004 Dec; 47(8):1146-56. PubMed ID: 15567424
[TBL] [Abstract][Full Text] [Related]
12. Role of gamma-aminobutyric acid (GABA) and metabotropic glutamate receptors in nicotine reinforcement: potential pharmacotherapies for smoking cessation.
Markou A; Paterson NE; Semenova S
Ann N Y Acad Sci; 2004 Oct; 1025():491-503. PubMed ID: 15542754
[TBL] [Abstract][Full Text] [Related]
13. Gamma-butyrolactone (GBL) disruption of passive avoidance learning in the day-old chick appears to be due to its effect on GABAB not gamma-hydroxybutyric [corrected] acid (GHB) receptors.
Sherry JM; Hazi A; Hale MW; Milsome SL; Crowe SF
Behav Brain Res; 2009 Feb; 197(2):347-55. PubMed ID: 18948143
[TBL] [Abstract][Full Text] [Related]
14. Role of GABA(B) receptors in the sedative/hypnotic effect of gamma-hydroxybutyric acid.
Carai MA; Colombo G; Brunetti G; Melis S; Serra S; Vacca G; Mastinu S; Pistuddi AM; Solinas C; Cignarella G; Minardi G; Gessa GL
Eur J Pharmacol; 2001 Oct; 428(3):315-21. PubMed ID: 11689189
[TBL] [Abstract][Full Text] [Related]
15. Beta and gamma range EEG power-spectrum correlation with spiking discharges in DBA/2J mice absence model: role of GABA receptors.
Marrosu F; Santoni F; Fà M; Puligheddu M; Barberini L; Genugu F; Frau R; Manunta M; Mereu G
Epilepsia; 2006 Mar; 47(3):489-94. PubMed ID: 16529610
[TBL] [Abstract][Full Text] [Related]
16. Pharmacological characterization of harmaline-induced tremor activity in mice.
Paterson NE; Malekiani SA; Foreman MM; Olivier B; Hanania T
Eur J Pharmacol; 2009 Aug; 616(1-3):73-80. PubMed ID: 19497322
[TBL] [Abstract][Full Text] [Related]
17. Cholecystokinin inhibits evoked inhibitory postsynaptic currents in the rat nucleus accumbens indirectly through gamma-aminobutyric acid and gamma-aminobutyric acid type B receptors.
Kombian SB; Ananthalakshmi KV; Parvathy SS; Matowe WC
J Neurosci Res; 2005 Feb; 79(3):412-20. PubMed ID: 15605383
[TBL] [Abstract][Full Text] [Related]
18. Sedative and hypothermic effects of gamma-hydroxybutyrate (GHB) in rats alone and in combination with other drugs: assessment using biotelemetry.
van Nieuwenhuijzen PS; McGregor IS
Drug Alcohol Depend; 2009 Aug; 103(3):137-47. PubMed ID: 19446408
[TBL] [Abstract][Full Text] [Related]
19. Withdrawal syndrome from gamma-hydroxybutyric acid (GHB) and 1,4-butanediol (1,4-BD) in Sardinian alcohol-preferring rats.
Carai MA; Quang LS; Atzeri S; Lobina C; Maccioni P; Orrù A; Gessa GL; Maher TJ; Colombo G
Brain Res Brain Res Protoc; 2005 Jul; 15(2):75-8. PubMed ID: 15886053
[TBL] [Abstract][Full Text] [Related]
20. Drosophila GABA(B) receptors are involved in behavioral effects of gamma-hydroxybutyric acid (GHB).
Dimitrijevic N; Dzitoyeva S; Satta R; Imbesi M; Yildiz S; Manev H
Eur J Pharmacol; 2005 Sep; 519(3):246-52. PubMed ID: 16129424
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
